VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 560 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2015. The put-call ratio across all filers is 2.18 and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $122,000 | +159.6% | 5,248 | +78.6% | 0.01% | +133.3% |
| Q1 2018 | $47,000 | -81.8% | 2,939 | -83.7% | 0.01% | -82.4% |
| Q3 2017 | $258,000 | +3125.0% | 17,994 | +5369.3% | 0.03% | +3300.0% |
| Q3 2016 | $8,000 | +166.7% | 329 | +92.4% | 0.00% | – |
| Q2 2016 | $3,000 | +50.0% | 171 | +87.9% | 0.00% | – |
| Q1 2016 | $2,000 | -71.4% | 91 | +28.2% | 0.00% | -100.0% |
| Q4 2015 | $7,000 | -70.8% | 71 | -47.8% | 0.00% | -80.0% |
| Q3 2015 | $24,000 | +9.1% | 136 | +34.7% | 0.01% | 0.0% |
| Q2 2015 | $22,000 | +175.0% | 101 | +165.8% | 0.01% | +150.0% |
| Q1 2015 | $8,000 | +100.0% | 38 | +8.6% | 0.00% | +100.0% |
| Q2 2014 | $4,000 | – | 35 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,106,379 | $55,398,000 | 31.67% |
| Claren Road Asset Management, LLC | 80,000 | $2,820,000 | 24.27% |
| Okumus Fund Management Ltd. | 3,722,464 | $97,901,000 | 15.82% |
| Wingspan Investment Management, LP | 852,900 | $22,431,000 | 12.66% |
| FARLEY CAPITAL L.P. | 307,458 | $8,086,000 | 11.46% |
| Chou Associates Management | 976,843 | $25,725,000 | 8.35% |
| Wingspan Investment Management, LP | 550,700 | $14,483,000 | 8.17% |
| HAP Trading, LLC | 4,043,900 | $109,610,000 | 8.00% |
| LeVasseur Capital Partners LLC | 128,269 | $3,373,000 | 6.97% |
| Pershing Square Capital Management | 21,591,122 | $567,847,000 | 6.41% |